Clearmind Medicine Inc. (CMND) quarterly income statement — complete revenue, gross profit & net income history
| Sales/Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Revenue Growth % | - | - | - | - | - | - | - | - | - | - | - | - |
| Cost of Goods Sold | 13.9K | 13.32K | 12.84K | 12.52K | 11.98K | 12.03K | 11.51K | 15.2K | 15.73K | 8.63K | 4.01K | 17.72K |
| COGS % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Gross Profit | -13.9K | -13.32K | -12.84K | -12.52K | -11.98K | -12.03K | -11.51K | -15.2K | -15.73K | -8.63K | -4.01K | -17.72K |
| Gross Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| Gross Profit Growth % | -16.05% | -10.7% | -11.51% | 17.6% | 23.85% | -39.38% | -186.99% | 14.25% | -47.91% | 60.79% | 89.05% | 70.45% |
| Operating Expenses | 1.56M | 3.64M | 1.44M | 1.4M | 1.3M | 1.48M | 1.57M | 1.46M | 1.29M | 1.38M | 1.71M | 1.07M |
| OpEx % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Selling, General & Admin | 913.27K | 3.01M | 1.03M | 674.95K | 846.46K | 1.02M | 1.09M | 1.11M | 967.09K | 1.15M | 1.33M | 812.14K |
| SG&A % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Research & Development | 644.04K | 637.34K | 417.38K | 720.29K | 449.52K | 458.43K | 483.73K | 343.25K | 320.11K | 224.75K | 374.56K | 261.1K |
| R&D % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Operating Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -1.57M | -3.66M | -1.46M | -1.41M | -1.31M | -1.5M | -1.59M | -1.47M | -1.3M | -1.38M | -1.71M | -1.09M |
| Operating Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating Income Growth % | -20.13% | -144.6% | 8.2% | 4.35% | -0.39% | -8.03% | 7.19% | -34.91% | 21.48% | 24.57% | -6.37% | 40.64% |
| EBITDA | -1.56M | -3.64M | -1.44M | -1.4M | -1.3M | -1.48M | -1.57M | -1.46M | -1.29M | -1.38M | -1.71M | -1.07M |
| EBITDA Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| EBITDA Growth % | -20.16% | -145.69% | 8.34% | 4.21% | -0.68% | -7.83% | 7.65% | -35.72% | 21.93% | 24.13% | -8.6% | 39.63% |
| D&A (Non-Cash Add-back) | 13.9K | 13.32K | 12.84K | 12.52K | 11.98K | 12.03K | 11.51K | 15.2K | 15.73K | 8.63K | 4.01K | 17.72K |
| EBIT | -1.57M | -3.84M | -685.59K | -1.3M | -755.96K | -1.02M | -1.19M | -2.05M | -871.08K | -1.17M | -4.05M | -575.53K |
| Net Interest Income | 37.79K | 60.5K | 24.66K | 23.4K | 33.8K | 25.28K | 55.51K | 85.06K | 33.94K | 60.58K | 17.86K | 17.12K |
| Interest Income | 42.02K | 64.61K | 24.66K | 32.59K | 41.68K | 33.99K | 91.67K | 85.06K | 33.94K | 60.58K | 17.86K | 17.12K |
| Interest Expense | 4.23K | 4.1K | 0 | 9.19K | 7.87K | 8.71K | 36.16K | 0 | 0 | 0 | 0 | 0 |
| Other Income/Expense | -473.13K | -190.59K | 770.54K | 102.43K | 544.12K | 463.64K | 798.55K | -580.3K | 431.85K | 217.73K | -2.34M | 515.43K |
| Pretax Income | -2.04M | -3.85M | -685.58K | -1.31M | -763.84K | -1.03M | -787.62K | -2.05M | -871.08K | -1.17M | -4.05M | -575.53K |
| Pretax Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| Income Tax | 3.31K | 3.96K | 2.19K | 8.26K | 20.67K | 39.31K | 97.12K | 42.6K | 36.74K | 201.53K | 11.34K | -6.56K |
| Effective Tax Rate % | -0.16% | -0.1% | -0.32% | -0.63% | -2.71% | -3.81% | -12.33% | -2.08% | -4.22% | -17.28% | -0.28% | 1.14% |
| Net Income | -2.05M | -3.85M | -687.78K | -1.31M | -784.51K | -1.07M | -884.74K | -2.09M | -907.82K | -1.37M | -4.06M | -568.97K |
| Net Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Income Growth % | -161.01% | -259.67% | 22.26% | 37.29% | 13.58% | 21.71% | 78.23% | -268.16% | 56.37% | 28.06% | -87.62% | 71.8% |
| Net Income (Continuing) | -2.05M | -3.85M | -687.78K | -1.31M | -784.51K | -1.07M | -884.74K | -2.09M | -907.82K | -1.37M | -4.06M | -568.97K |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -6.78 | -3.32 | -0.48 | -0.98 | -0.62 | -0.95 | -0.83 | -2.35 | -1.12 | -3.61 | -45.69 | -9.63 |
| EPS Growth % | -993.55% | -249.47% | 42.17% | 58.3% | 44.64% | 73.68% | 98.18% | 75.6% | 98.32% | 96.36% | 76.8% | 94.75% |
| EPS (Basic) | -6.78 | -3.32 | -0.48 | -0.98 | -0.62 | -0.95 | -0.83 | -2.35 | -1.12 | -3.61 | -45.69 | -9.63 |
| Diluted Shares Outstanding | 301.96K | 1.16M | 1.44M | 1.34M | 1.26M | 1.12M | 1.07M | 889.96K | 813.31K | 379.36K | 88.94K | 59.07K |
| Basic Shares Outstanding | 301.96K | 1.16M | 1.44M | 1.34M | 1.26M | 1.12M | 1.07M | 889.96K | 813.31K | 379.36K | 88.94K | 59.07K |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - |